Valuation: Ark Therapeutics Group plc

Market Cap 5.29M 7.08M 6.21M 5.73M 10.04M 678M 10.24M 68.88M 26.76M 332M 26.57M 25.99M 1.15B P/E 2024
1.51x
P/E 2025 -
Enterprise Value -9.39M -12.55M -11.01M -10.16M -17.8M -1.2B -18.16M -122M -47.48M -588M -47.14M -46.11M -2.04B EV / Sales 2024
-0.1x
EV / Sales 2025 -0.56x
Free-Float
-
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Chief Executive Officer 69 26/02/2015
Director of Finance/CFO 52 29/11/2018
Director TitleAgeSince
Chairman 75 28/02/2018
Director/Board Member 69 26/02/2015
Director/Board Member 63 26/02/2015

Financials

2024 2025
Net sales 16.53M 22.09M 19.38M 17.89M 31.33M 2.12B 31.96M 215M 83.55M 1.04B 82.96M 81.14M 3.59B 16.85M 22.52M 19.75M 18.23M 31.94M 2.16B 32.57M 219M 85.17M 1.06B 84.56M 82.7M 3.66B
Net income 3.9M 5.22M 4.58M 4.23M 7.4M 500M 7.55M 50.8M 19.74M 245M 19.6M 19.17M 849M 3.64M 4.87M 4.27M 3.94M 6.91M 466M 7.05M 47.41M 18.42M 228M 18.29M 17.89M 792M
Net Debt -6.94M -9.27M -8.13M -7.51M -13.15M -888M -13.42M -90.28M -35.08M -435M -34.83M -34.07M -1.51B -14.69M -19.63M -17.22M -15.89M -27.84M -1.88B -28.4M -191M -74.24M -920M -73.71M -72.1M -3.19B
Logo Ark Therapeutics Group plc
Premier Veterinary Group plc, formerly Ark Therapeutics Group plc, operates various veterinary practices and provides non-medical services to other veterinary practices. The Company operates through segments, including Vets Business, Pet Care Plan and Pet Care Plan overseas. The Vets Business segment is engaged in day to day running of veterinary practices. Its Pet Care Plan is the fees received for the collection and management of direct debits on behalf of veterinary practices external to the Company. The Company's Pet Care Plan is divided into the United Kingdom and overseas. The Company, through its subsidiary, Premier Vet Alliance Limited (PVA), is a provider of services to veterinary practices, including the administration of a preventative healthcare program for pets branded Pet Care Plan.
Employees
-
Sector
-